Viva Biotech Holdings (OTCMKTS:VBIZF – Get Free Report)’s stock price fell 32.5% on Wednesday . The company traded as low as $0.11 and last traded at $0.11. 3,500 shares changed hands during mid-day trading, an increase of 127% from the average session volume of 1,544 shares. The stock had previously closed at $0.17.
Viva Biotech Price Performance
The company has a 50 day simple moving average of $0.13 and a 200-day simple moving average of $0.09.
About Viva Biotech
Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, including protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; and antibody/biologics research and development services comprising recombinant protein expression platform, antibody discovery and affinity maturation, assay platform, antibody production and identification platform, and antigen-antibody structural resolution platform solutions.
Featured Articles
- Five stocks we like better than Viva Biotech
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- ETF Screener: Uses and Step-by-Step Guide
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Viva Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viva Biotech and related companies with MarketBeat.com's FREE daily email newsletter.